Despite having a longer life expectancy compared to men, women in the U.S. generally have a higher prevalence of chronic conditions. Complicating matters, women’s health remains underfunded and understudied at both a federal level and in the private sector.
A new report, The Veradigm 2026 Women’s Health Report, draws on the latest data from the Veradigm Network EHR linked to administrative claims. It offers an overview of real-world evidence across adolescence, reproductive years, and peri-/post-menopause. Each phase includes unique biologic, hormonal, and psychosocial factors that influence disease risk, preventive care engagement, therapeutic decision- making, and health outcomes.
Through this lens, the report examines key clinical trends, comorbidity profiles, and treatment trends across these stages, illustrating the power of real-world data to study female-specific and female-dominant conditions at scale.
